Purchase Order 36C24426P0229

The Department of Veterans Affairs, Veterans Integrated Service Network 4 (VISN 4) awarded a $49,748.73 firm fixed-price purchase order to Novocure Inc. for Optune Plus transducers on March 18, 2026, with an ultimate completion date of June 18, 2026. The award was issued without a set-aside designation and is being performed in Butler, Pennsylvania. Novocure Inc., a foreign-owned medical device manufacturer specializing in innovative cancer treatment technologies, supplies the Optune system, which utilizes Tumor Treating Fields (TTFields) technology for non-invasive treatment of solid tumor cancers, including FDA-approved applications for glioblastoma and mesothelioma. This purchase order is issued under Novocure's existing Federal Supply Schedule contract (FSS-65-II-A) with the Veterans Health Administration, a $28.85 million multiple-award vehicle established on November 1, 2022, and extending through October 31, 2027.

Novocure serves as the sole source provider of Optune devices and transducer components to the VA, with this purchase order representing one of over 100 task orders issued under the FSS contract vehicle across VISNs nationwide. The company operates as the prime contractor on all awards with no subcontractor involvement, ensuring direct control and quality assurance over its proprietary medical device technologies. These procurements support the Veterans Health Administration's strategic objective to expand veterans' access to cutting-edge, non-invasive cancer treatment options across multiple medical facilities throughout the veterans' healthcare network.